Clinical Trial Update: Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and efficacy of donepezil in mild-to-moderate Alzheimer's disease has completed, with results posted in August 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2024-08-23